NCT06727981View on ClinicalTrials.gov

First-Line and Neoadjuvant Immunotherapy for Gastric Cancer

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 15, 2022

Primary Completion Date

January 15, 2027

Study Completion Date

January 15, 2028

Conditions
Advanced Gastric CancerLocally Advanced Gastric Carcinoma
Interventions
DRUG

ICI plus Chemothearpy

This intervention involves the administration of immune checkpoint inhibitors (ICIs) in combination with standard chemotherapy.

DRUG

Chemotherapy

This intervention involves the administration of standard chemotherapy alone.

Trial Locations (1)

250012

RECRUITING

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors
lead

Qilu Hospital of Shandong University

OTHER